APPLICATIONS PUBLISHED 12 MARCH 2003
Published: 1-Sep-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Non-toxic coating compsn, methods of use thereof and articles protected from attachment of biofouling organisms
Matias, Jonathan 1289361*
Use of amine compounds with improved biodegradability as adjuvants for pesticides and fertilisers
Akzo Nobel 1289362*
Sustained release compsn comprising an active agent in a plastic carrier and shaped articles made therefrom
Rosza, Laszlo; Marossy, Kalman; Honti, Eva; Szegoe, Andras; Neder, Andras 1289363*
Stable ganapentin containing more than 20ppm of chlorine ion
Teva Pharmaceutical Industries 1289364*
Use of phenethyl acrylamides, novel phenethyl acrylamides, method for the production thereof and agents containing the same
BASF 1289365*
Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-D-glucopyranoside
Pentapharm; Ezaki Glico 1289489*
Stabilised compsns containing oxygen-labile active agents
Neutrogena Corp 1289490*
Cosmetic compsn comprising human serum albumin obtained from transgenic non-human animals
Fresenius Kabi 1289492*
Pharmaceutical compsns comprising desglymidorine as an active drug substance
Nycomed Austria 1289493*
Powder compsns
Powderject Vaccines 1289494*
Process for the preparation of a sterile ointment containing acyclovir
Egis Gyogyszergyar 1289495*
Novel aqueous anti-inflammatory pharmaceutical formulation
Glaxo Group 1289497*
Novel pharmaceutical formulation suitable for nebulisation
Glaxo Group 1289498*
Pharmaceutical anti-inflammatory aerosol formulation
Glaxo Group 1289499*
Novel pharmaceutical formulation suitable for nebulisation
Glaxo Group 1289500*
Novel aqueous anti-inflammatory pharmaceutical formulation
Glaxo Group 1289501*
Microemulsion preconcentrates, microemulsion and use of such a compsn
Vesifact 1289502*
O/W emulsion
AstraZeneca 1289503*
Neurotoxin implant
Allergan 1289504*
Novel process
AstraZeneca 1289505*
Novel compsn
AstraZeneca 1289506*
Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
Pharmacia 1289507*
Method for the prevention of apoptosis
Charlotte-Mecklenburg Hospital doing business as Carolinas Medical Center 1289508*
Compsns containing naphthaquinone and an antiproliferative agent
Chemgenex Therapeutics 1289509*
Compsns, kits, and methods for promoting defined health benefits
Procter & Gamble 1289510*
Bactericidal preparation
Boeck, Harry 1289511*
Agents and methods for increasing brain chaperonin levels
Holtzman, Jordan 1289512*
Use of aloe-emodin in the treatment of neuroectodermal tumours
Universita' Degli Studi di Padova 1289513*
Use of substituted 1-amino-5-phenylpentane-3-ol compounds as medicaments
Gruenenthal 1289514*
Pharmaceutical compsn containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof
Biodex 1289515*
Compsn for pain mediation and apparatus and method of use thereof
Palladin HealthCare International 1289516*
Pharmaceutical compsns comprising cannabidiol derivatives
Yissum Research Development Company of the Hebrew University of Jerusalem 1289517*
Pharmaceutical compsn comprising a free-radical scavenging sedative agent and a metal ion chelating agent
AstraZeneca 1289518*
Method of treating androgen deficiency in men using selective antioestrogens
Fisch, Harry 1289519*
Pharmaceutical compsn for the treatment of depression comprising famotidine
Richter Gedeon Vegyszeti Gyar 1289520*
Combination of lipoic acid and C1 donors for the treatment of disorders of the central nervous system
BASF 1289521*
Medicaments for treating dementia
Viatris 1289522*
Use of (di-substituted-phenyl)-pyridinyl-imidazole derivatives as JNK-inhibitors
Merck; Merck Frosst Canada; Merck Sharpe & Dohme 1289523*
Porous celecoxib matrices and methods of manufacture thereof
Acusphere 1289524*
Tricyclic pyrazole derivatives as protein kinase inhibitors
Abbott 1289525*
Melanocortin receptor agonists
Merck 1289526*
Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
Aventis Pharmaceuticals 1289527*
Active substance combination containing an opioid having a fentanyl-type structure and ketamine
Gruenenthal 1289528*
Active substance combination containing a compound with an opioid effect and at least one further compound of formula 1
Gruenenthal 1289529*
Lipids for modulating immune response
Porter, William Leslie 1289530*
Kits and methods for optimising the efficacy of chrodroprotective compsns
Procter & Gamble 1289531*
Low carbohydrate compsns, kits thereof, and methods of use
Procter & Gamble 1289532*
Apoptotic entities for use in treatment of T-cell mediated and inflammatory disorders
Vasogen Ireland 1289534*
Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
Vasogen Ireland 1289535*
Apoptotic entities for use in treatment of endothelium dysfunction disorders
Vasogen Ireland 1289536*
Method of treating chronic ulcers
Encelle 1289537*
Compsns for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
Theralfie 1289538*
Pharmaceutical anti-inflammatory aerosol formulation
Glaxo Group 1289539*
Methods and compsns for producing a neurosalutary effect in a subject
Children's Medical Center Corp 1289540*
Interferon for the treatment of multiple sclerosis
Schering 1289541*
Means for maintenance and/or correction of glucose concentration in blood
CTP Cable Technology Procurement 1289542*
Formulations and methods for treating hypercoagulable states
Eli Lilly 1289543*
Method for treating a movement disorder
Allergan 1289544*
Synthetic vaccine for tick control
Universidade Federal de Vi Osa; Fundacao De Amparo A Pesquisa Do Estado De Minas Gerais 1289545*
